HRS-6208

HRS-6208 · Shandong Suncadia Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HRS-6208, covering 2025-12-18 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer [Phase 1, Phase 2]

See pricing